Trinity Biotech | TRIB - Cash And Equivalent

Trinity Biotech reported $7.25M in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cash And Equivalent Change
Bayer BAYN:GR EUR 5.17B 810M
Bio Rad Laboratories BIO:US USD 434.22M 83.73M
Cytori Therapeutics CYTX:US USD 18.12M 2.15M
Edap Tms EDAP:US EUR 46.33M 164K
Mesa Laboratories MLAB:US USD 26.1M 6.28M
Orasure Technologies OSUR:US USD 83.98M 8.78M
Roche Holding ROG:VX 4.99B 676M
Siemens SIE:GR EUR 10.14B 330M
Sientra SIEN:US USD 18.97M 6.02M
Surmodics SRDX:US USD 26.43M 7.43M
Thermo Fisher Scientific TMO:US USD 8.52B 5.6B
Tosoh 4042:JP JPY 119.78B 4.07B
Veracyte VCYT:US USD 154.25M 15.86M